These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2515135)

  • 21. Malignant hypertension in HIV-associated glomerulonephritis.
    Morales E; Gutierrez-Solis E; Gutierrez E; González R; Martínez MA; Praga M
    Nephrol Dial Transplant; 2008 Dec; 23(12):3901-7. PubMed ID: 18647741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term prognosis in malignant or accelerated hypertension.
    Guerin C; Gonthier R; Berthoux FC
    Nephrol Dial Transplant; 1988; 3(1):33-7. PubMed ID: 3132637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of malignant hypertension with an angiotensin converting enzyme inhibitor.
    Cottone S; Mangano MT; Fulantelli MA; Cerasola G; Salerno L; Nardi E; Lodato G; Traina C
    Clin Ther; 1989; 11(4):511-20. PubMed ID: 2550135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension in end-stage renal disease. The relationship between blood pressure, plasma renin, plasma renin substrate and exchangeable sodium in chronic hemodialysis patients.
    Kornerup HJ
    Acta Med Scand; 1976; 200(4):257-61. PubMed ID: 10715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlations between heart rate variability, renin activity and plasma aldosteron concentration in chronic glomerulonephritis with intact function of the kidneys].
    Borovkova NIu; Borovkov NN; Sidnev BN; Obukhova EO
    Ter Arkh; 2009; 81(8):20-3. PubMed ID: 19799195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure.
    Borghi C; Veronesi M; Cosentino E; Cicero AF; Kuria F; Dormi A; Ambrosioni E
    J Hypertens; 2007 Oct; 25(10):2051-7. PubMed ID: 17885547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of minoxidil in the treatment of malignant hypertension in chronic renal failure.
    Mutterperl RE; Diamond FB; Lowenthal DT
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):498-509. PubMed ID: 789412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertension in primary glomerulonephritis without renal insufficiency.
    Zucchelli P; Zuccalà A; Mancini E
    Nephrol Dial Transplant; 1989; 4(7):605-10. PubMed ID: 2510057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The malignant hypertension syndrome: incontrovertible and questionable truths].
    Shulutko BI; Konstantinov IuV
    Ter Arkh; 1990; 62(6):121-4. PubMed ID: 2218909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fundus hypertonicus malignus. Increased incidence in renal parenchymal diseases].
    Heidbreder E; Hüller U; Schäfer B; Heidland A
    Dtsch Med Wochenschr; 1986 Mar; 111(11):411-6. PubMed ID: 3948702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis of chronic renal failure. II. Factors affecting survival.
    Maher JF; Bryan CW; Ahearn DJ
    Arch Intern Med; 1975 Feb; 135(2):273-8. PubMed ID: 1147731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term renal survival in malignant hypertension.
    González R; Morales E; Segura J; Ruilope LM; Praga M
    Nephrol Dial Transplant; 2010 Oct; 25(10):3266-72. PubMed ID: 20299339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The significance of microproteinuria for the diagnosis of kidney involvement in hypertensive disease and secondary forms of arterial hypertension].
    Fomenko GV; Lipitskaia IIa; Tuminen T; Babaeva NI; Arabidze GG; Titov VN
    Ter Arkh; 1992; 64(4):30-3. PubMed ID: 1440304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features of end-stage renal failure in patients with essential hypertension.
    Oda H; Tanaka S; Satta H; Tokita Y; Takagi N; Ishii M
    Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):382-8. PubMed ID: 8022111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of malignant hypertension in whom steroid improved renal function].
    Sasaki N; Ando Y; Ootomo T; Ishiharajima S; Kusano E; Asano Y
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):818-24. PubMed ID: 10655731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The renin-angiotensin system and the pathogenesis of vascular disease in malignant hypertension.
    Geise J
    Clin Sci Mol Med Suppl; 1976 Dec; 3():19s-21s. PubMed ID: 1071605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy and prognosis of hypertension in chronic nephritis.
    Kajiwara N
    Jpn Circ J; 1975 Jul; 39(7):779-86. PubMed ID: 1159936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diazoxide in the management of severe hypertension.
    Moller BB; Kolendorf K
    Acta Med Scand; 1975 Nov; 198(5):358-8. PubMed ID: 1199811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin test for differentiation of unilateral renovascular hypertension from hyperreninemic essential hypertension.
    Imanishi M; Ohta M; Kawamura M; Akabane S; Matsushima Y; Kuramochi M; Kojima S; Kimura K; Takamiya M; Ito K
    Am J Hypertens; 1991 Sep; 4(9):761-8. PubMed ID: 1930860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.